X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Clinical Trials News - 03/Mar 20:03

Omalizumab Treats Multi-Food Allergy Better Than Oral Immunotherapy

Monday, March 3, 2025 -- A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small amounts of common food...

Articles similaires

Sorry! Image not available at this time

Injectable Drug Xolair Resolves Dangerous Food Allergies In One-Third Of Kids

drugs.com - 03/Mar 11:03

MONDAY, March 3, 2025 -- More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an...

Sorry! Image not available at this time

AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy

drugs.com - 03/Mar 17:07

MONDAY, March 3, 2025 -- Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC)...

Sorry! Image not available at this time

FDA Approves Omlyclo (omalizumab-igec), an Interchangeable Biosimilar to Xolair

drugs.com - 07/Mar 22:03

March 07, 2025 -- Today, the U.S. Food and Drug Administration approved as the first interchangeable biosimilar to Xolair (omalizumab). Omlyclo, like...

Sorry! Image not available at this time

Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies

drugs.com - 02/Mar 22:03

South San Francisco, CA -- March 2, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new positive data...

Sorry! Image not available at this time

ARS Pharmaceuticals Announces FDA Approval of neffy 1 mg (epinephrine nasal spray) for Type I Allergic Reactions in Pediatric Patients

drugs.com - 05/Mar 02:03

SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk...

Sorry! Image not available at this time

FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children

drugs.com - 05/Mar 22:08

WEDNESDAY, March 5, 2025 -- The U.S. Food and Drug Administration has expanded its indication of Odactra, a house dust mite allergen tablet, for the...

Common Diabetes Medication Reduces Heart Failure Risk in Cancer Patients

medindia.net - 07/Mar 18:22

SGLT2 inhibitors, a diabetes medication, may protect the heart and reduce hospitalizations for cancer patients, particularly those treated with...

Trial shows PACE food labeling reduces sugary food purchases in schools

news.medical.net - 07/Mar 13:01

A trial at English secondary schools of alternative food labeling - which displayed the number of minutes of physical activity needed to burn off...

Stem cell therapy for cornea injuries demonstrates remarkable results in clinical trial

news.medical.net - 04/Mar 12:02

An expanded clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries found the treatment was...

Vitamin E supplement may reduce food allergies in newborns

knowridge.com - 24/Feb 14:57

A new study has found that a form of vitamin E, called α-tocopherol, may help reduce food allergies and severe allergic reactions in newborns when...